IBDEI2ED ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,38254,1,3,0)
;;=3^PT EVALUATION,MODERATE COMPLEXITY
;;^UTILITY(U,$J,358.3,38255,0)
;;=97163^^148^1939^14^^^^1
;;^UTILITY(U,$J,358.3,38255,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38255,1,2,0)
;;=2^97163
;;^UTILITY(U,$J,358.3,38255,1,3,0)
;;=3^PT EVALUATION,HIGH COMPLEXITY
;;^UTILITY(U,$J,358.3,38256,0)
;;=97165^^148^1939^11^^^^1
;;^UTILITY(U,$J,358.3,38256,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38256,1,2,0)
;;=2^97165
;;^UTILITY(U,$J,358.3,38256,1,3,0)
;;=3^OT Evaluation,Low Complexity
;;^UTILITY(U,$J,358.3,38257,0)
;;=97166^^148^1939^12^^^^1
;;^UTILITY(U,$J,358.3,38257,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38257,1,2,0)
;;=2^97166
;;^UTILITY(U,$J,358.3,38257,1,3,0)
;;=3^OT Evaluation,Moderate Complexity
;;^UTILITY(U,$J,358.3,38258,0)
;;=97167^^148^1939^10^^^^1
;;^UTILITY(U,$J,358.3,38258,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38258,1,2,0)
;;=2^97167
;;^UTILITY(U,$J,358.3,38258,1,3,0)
;;=3^OT Evaluation,High Complexity
;;^UTILITY(U,$J,358.3,38259,0)
;;=97129^^148^1939^20^^^^1
;;^UTILITY(U,$J,358.3,38259,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38259,1,2,0)
;;=2^97129
;;^UTILITY(U,$J,358.3,38259,1,3,0)
;;=3^THERAPEUTIC INTVN,COG FUNC,1ST 15 MIN
;;^UTILITY(U,$J,358.3,38260,0)
;;=97130^^148^1939^21^^^^1
;;^UTILITY(U,$J,358.3,38260,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38260,1,2,0)
;;=2^97130
;;^UTILITY(U,$J,358.3,38260,1,3,0)
;;=3^THERAPEUTIC INTVN,COG FUNC,EA ADDL 15 MIN
;;^UTILITY(U,$J,358.3,38261,0)
;;=95851^^148^1940^17^^^^1
;;^UTILITY(U,$J,358.3,38261,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38261,1,2,0)
;;=2^95851
;;^UTILITY(U,$J,358.3,38261,1,3,0)
;;=3^ROM MEASURE,EACH EXT/SPINE
;;^UTILITY(U,$J,358.3,38262,0)
;;=95852^^148^1940^18^^^^1
;;^UTILITY(U,$J,358.3,38262,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38262,1,2,0)
;;=2^95852
;;^UTILITY(U,$J,358.3,38262,1,3,0)
;;=3^ROM MEASUREMENT,HANDS
;;^UTILITY(U,$J,358.3,38263,0)
;;=95857^^148^1940^1^^^^1
;;^UTILITY(U,$J,358.3,38263,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38263,1,2,0)
;;=2^95857
;;^UTILITY(U,$J,358.3,38263,1,3,0)
;;=3^CHOLINESTERASE INHIB CHALLENGE
;;^UTILITY(U,$J,358.3,38264,0)
;;=95860^^148^1940^5^^^^1
;;^UTILITY(U,$J,358.3,38264,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38264,1,2,0)
;;=2^95860
;;^UTILITY(U,$J,358.3,38264,1,3,0)
;;=3^EMG,ONE EXTREMITY
;;^UTILITY(U,$J,358.3,38265,0)
;;=95861^^148^1940^8^^^^1
;;^UTILITY(U,$J,358.3,38265,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38265,1,2,0)
;;=2^95861
;;^UTILITY(U,$J,358.3,38265,1,3,0)
;;=3^EMG,TWO EXTREMITIES
;;^UTILITY(U,$J,358.3,38266,0)
;;=95863^^148^1940^7^^^^1
;;^UTILITY(U,$J,358.3,38266,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38266,1,2,0)
;;=2^95863
;;^UTILITY(U,$J,358.3,38266,1,3,0)
;;=3^EMG,THREE EXTREMITIES
;;^UTILITY(U,$J,358.3,38267,0)
;;=95864^^148^1940^4^^^^1
;;^UTILITY(U,$J,358.3,38267,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38267,1,2,0)
;;=2^95864
;;^UTILITY(U,$J,358.3,38267,1,3,0)
;;=3^EMG,FOUR EXTREMITIES
;;^UTILITY(U,$J,358.3,38268,0)
;;=95867^^148^1940^3^^^^1
;;^UTILITY(U,$J,358.3,38268,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,38268,1,2,0)
;;=2^95867
;;^UTILITY(U,$J,358.3,38268,1,3,0)
;;=3^EMG,CRANIAL NERVE,UNILAT
;;^UTILITY(U,$J,358.3,38269,0)
;;=95868^^148^1940^2^^^^1
;;^UTILITY(U,$J,358.3,38269,1,0)
;;=^358.31IA^3^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2ED 3772 printed Apr 09, 2024@20:56:01 Page 2
IBDEI2ED ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,38254,1,3,0)
+2 ;;=3^PT EVALUATION,MODERATE COMPLEXITY
+3 ;;^UTILITY(U,$J,358.3,38255,0)
+4 ;;=97163^^148^1939^14^^^^1
+5 ;;^UTILITY(U,$J,358.3,38255,1,0)
+6 ;;=^358.31IA^3^2
+7 ;;^UTILITY(U,$J,358.3,38255,1,2,0)
+8 ;;=2^97163
+9 ;;^UTILITY(U,$J,358.3,38255,1,3,0)
+10 ;;=3^PT EVALUATION,HIGH COMPLEXITY
+11 ;;^UTILITY(U,$J,358.3,38256,0)
+12 ;;=97165^^148^1939^11^^^^1
+13 ;;^UTILITY(U,$J,358.3,38256,1,0)
+14 ;;=^358.31IA^3^2
+15 ;;^UTILITY(U,$J,358.3,38256,1,2,0)
+16 ;;=2^97165
+17 ;;^UTILITY(U,$J,358.3,38256,1,3,0)
+18 ;;=3^OT Evaluation,Low Complexity
+19 ;;^UTILITY(U,$J,358.3,38257,0)
+20 ;;=97166^^148^1939^12^^^^1
+21 ;;^UTILITY(U,$J,358.3,38257,1,0)
+22 ;;=^358.31IA^3^2
+23 ;;^UTILITY(U,$J,358.3,38257,1,2,0)
+24 ;;=2^97166
+25 ;;^UTILITY(U,$J,358.3,38257,1,3,0)
+26 ;;=3^OT Evaluation,Moderate Complexity
+27 ;;^UTILITY(U,$J,358.3,38258,0)
+28 ;;=97167^^148^1939^10^^^^1
+29 ;;^UTILITY(U,$J,358.3,38258,1,0)
+30 ;;=^358.31IA^3^2
+31 ;;^UTILITY(U,$J,358.3,38258,1,2,0)
+32 ;;=2^97167
+33 ;;^UTILITY(U,$J,358.3,38258,1,3,0)
+34 ;;=3^OT Evaluation,High Complexity
+35 ;;^UTILITY(U,$J,358.3,38259,0)
+36 ;;=97129^^148^1939^20^^^^1
+37 ;;^UTILITY(U,$J,358.3,38259,1,0)
+38 ;;=^358.31IA^3^2
+39 ;;^UTILITY(U,$J,358.3,38259,1,2,0)
+40 ;;=2^97129
+41 ;;^UTILITY(U,$J,358.3,38259,1,3,0)
+42 ;;=3^THERAPEUTIC INTVN,COG FUNC,1ST 15 MIN
+43 ;;^UTILITY(U,$J,358.3,38260,0)
+44 ;;=97130^^148^1939^21^^^^1
+45 ;;^UTILITY(U,$J,358.3,38260,1,0)
+46 ;;=^358.31IA^3^2
+47 ;;^UTILITY(U,$J,358.3,38260,1,2,0)
+48 ;;=2^97130
+49 ;;^UTILITY(U,$J,358.3,38260,1,3,0)
+50 ;;=3^THERAPEUTIC INTVN,COG FUNC,EA ADDL 15 MIN
+51 ;;^UTILITY(U,$J,358.3,38261,0)
+52 ;;=95851^^148^1940^17^^^^1
+53 ;;^UTILITY(U,$J,358.3,38261,1,0)
+54 ;;=^358.31IA^3^2
+55 ;;^UTILITY(U,$J,358.3,38261,1,2,0)
+56 ;;=2^95851
+57 ;;^UTILITY(U,$J,358.3,38261,1,3,0)
+58 ;;=3^ROM MEASURE,EACH EXT/SPINE
+59 ;;^UTILITY(U,$J,358.3,38262,0)
+60 ;;=95852^^148^1940^18^^^^1
+61 ;;^UTILITY(U,$J,358.3,38262,1,0)
+62 ;;=^358.31IA^3^2
+63 ;;^UTILITY(U,$J,358.3,38262,1,2,0)
+64 ;;=2^95852
+65 ;;^UTILITY(U,$J,358.3,38262,1,3,0)
+66 ;;=3^ROM MEASUREMENT,HANDS
+67 ;;^UTILITY(U,$J,358.3,38263,0)
+68 ;;=95857^^148^1940^1^^^^1
+69 ;;^UTILITY(U,$J,358.3,38263,1,0)
+70 ;;=^358.31IA^3^2
+71 ;;^UTILITY(U,$J,358.3,38263,1,2,0)
+72 ;;=2^95857
+73 ;;^UTILITY(U,$J,358.3,38263,1,3,0)
+74 ;;=3^CHOLINESTERASE INHIB CHALLENGE
+75 ;;^UTILITY(U,$J,358.3,38264,0)
+76 ;;=95860^^148^1940^5^^^^1
+77 ;;^UTILITY(U,$J,358.3,38264,1,0)
+78 ;;=^358.31IA^3^2
+79 ;;^UTILITY(U,$J,358.3,38264,1,2,0)
+80 ;;=2^95860
+81 ;;^UTILITY(U,$J,358.3,38264,1,3,0)
+82 ;;=3^EMG,ONE EXTREMITY
+83 ;;^UTILITY(U,$J,358.3,38265,0)
+84 ;;=95861^^148^1940^8^^^^1
+85 ;;^UTILITY(U,$J,358.3,38265,1,0)
+86 ;;=^358.31IA^3^2
+87 ;;^UTILITY(U,$J,358.3,38265,1,2,0)
+88 ;;=2^95861
+89 ;;^UTILITY(U,$J,358.3,38265,1,3,0)
+90 ;;=3^EMG,TWO EXTREMITIES
+91 ;;^UTILITY(U,$J,358.3,38266,0)
+92 ;;=95863^^148^1940^7^^^^1
+93 ;;^UTILITY(U,$J,358.3,38266,1,0)
+94 ;;=^358.31IA^3^2
+95 ;;^UTILITY(U,$J,358.3,38266,1,2,0)
+96 ;;=2^95863
+97 ;;^UTILITY(U,$J,358.3,38266,1,3,0)
+98 ;;=3^EMG,THREE EXTREMITIES
+99 ;;^UTILITY(U,$J,358.3,38267,0)
+100 ;;=95864^^148^1940^4^^^^1
+101 ;;^UTILITY(U,$J,358.3,38267,1,0)
+102 ;;=^358.31IA^3^2
+103 ;;^UTILITY(U,$J,358.3,38267,1,2,0)
+104 ;;=2^95864
+105 ;;^UTILITY(U,$J,358.3,38267,1,3,0)
+106 ;;=3^EMG,FOUR EXTREMITIES
+107 ;;^UTILITY(U,$J,358.3,38268,0)
+108 ;;=95867^^148^1940^3^^^^1
+109 ;;^UTILITY(U,$J,358.3,38268,1,0)
+110 ;;=^358.31IA^3^2
+111 ;;^UTILITY(U,$J,358.3,38268,1,2,0)
+112 ;;=2^95867
+113 ;;^UTILITY(U,$J,358.3,38268,1,3,0)
+114 ;;=3^EMG,CRANIAL NERVE,UNILAT
+115 ;;^UTILITY(U,$J,358.3,38269,0)
+116 ;;=95868^^148^1940^2^^^^1
+117 ;;^UTILITY(U,$J,358.3,38269,1,0)
+118 ;;=^358.31IA^3^2
